RR

Rajiv Ranjan

Active Director Director DIN 11611916
DIN 11611916 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajiv Ranjan

Data last updated:

Rajiv Ranjan is a Director at Larg Pharma Private Limited (since 2026).

DIN 11611916
Primary Designation Director
First Appointment 17 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Larg Pharma Private Limited U46497DC2026PTC469666
Director17 Mar 20262026Active

Board colleagues of Rajiv Ranjan

NameDINCompanyDesignation
Komal Kumari11611917Larg Pharma Private LimitedDirector
Shobha Rani Sharma11611918Larg Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Larg Pharma Private Limited
Premium access

Shareholding and investment profile for Rajiv Ranjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Ranjan

Rajiv Ranjan currently holds 1 directorship: Larg Pharma Private Limited (Director, since 17 Mar 2026).

Rajiv Ranjan was first appointed on 17 Mar 2026 as Director at Larg Pharma Private Limited.

The current boards of Rajiv Ranjan's companies include Komal Kumari (Larg Pharma Private Limited), Shobha Rani Sharma (Larg Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available